International Journal of Stem Cells

Korean Society for Stem Cell Research (한국줄기세포학회)
권호 표지
DOI QR코드

DOI QR Code

Guidelines for Manufacturing and Application of Organoids: Skin

  • Received : 2024.04.08
  • Accepted : 2024.05.12
  • Published : 2024.05.30
Download PDF
⟨ Previous Next ⟩

Abstract

To address the limitations of animal testing, scientific research is increasingly focused on developing alternative testing methods. These alternative tests utilize cells or tissues derived from animals or humans for in vitro testing, as well as artificial tissues and organoids. In western countries, animal testing for cosmetics has been banned, leading to the adoption of artificial skin for toxicity evaluation, such as skin corrosion and irritation assessments. Standard guidelines for skin organoid technology becomes necessary to ensure consistent data and evaluation in replacing animal testing with in vitro methods. These guidelines encompass aspects such as cell sourcing, culture techniques, quality requirements and assessment, storage and preservation, and organoid-based assays.

Keywords

Acknowledgement

The work was supported by the grant (23212MFDS265) from the Ministry of Food and Drug Safety in 2023.

References

  1. Jung SY, You HJ, Kim MJ, Ko G, Lee S, Kang KS. Wnt-activating human skin organoid model of atopic dermatitis induced by Staphylococcus aureus and its protective effects by Cutibacterium acnes. iScience 2022;25:105150
  2. Corsini NS, Knoblich JA. Human organoids: new strategies and methods for analyzing human development and disease. Cell 2022;185:2756-2769 https://doi.org/10.1016/j.cell.2022.06.051
  3. Wang Y, Wang P, Qin J. Human organoids and organson-chips for addressing COVID-19 challenges. Adv Sci (Weinh) 2022;9:e2105187
  4. Silva RJ, Tamburic S. A state-of-the-art review on the alternatives to animal testing for the safety assessment of cosmetics. Cosmetics 2022;9:90
  5. Wang M, Zhang L, Hao H, Yan M, Zhu Z. Applications of engineered skin tissue for cosmetic component and toxicology detection. Cell Transplant 2024;33:9636897241235464
  6. Deshmukh GR, Kumar KH, Reddy PV, Rao BS. In vitro skin corrosion: human skin model test - a validation study. Toxicol In Vitro 2012;26:1072-1074 https://doi.org/10.1016/j.tiv.2012.04.021
  7. OECD. Test No. 498: in vitro phototoxicity - reconstructed human epidermis phototoxicity test method. OECD; 2023.
  8. OECD. Test No. 439: in vitro skin irritation: reconstructed human epidermis test method. OECD; 2021.
  9. OECD. Test No. 431: in vitro skin corrosion: reconstructed human epidermis (RHE) test method. OECD; 2019.
  10. Moniz T, Costa Lima SA, Reis S. Human skin models: from healthy to disease-mimetic systems; characteristics and applications. Br J Pharmacol 2020;177:4314-4329 https://doi.org/10.1111/bph.15184
  11. Lee J, Koehler KR. Skin organoids: a new human model for developmental and translational research. Exp Dermatol 2021;30:613-620
  12. Lee J, Rabbani CC, Gao H, et al. Hair-bearing human skin generated entirely from pluripotent stem cells. Nature 2020;582:399-404 https://doi.org/10.1038/s41586-020-2352-3
  13. Kim J, Koo BK, Knoblich JA. Human organoids: model systems for human biology and medicine. Nat Rev Mol Cell Biol 2020;21:571-584 https://doi.org/10.1038/s41580-020-0259-3
  14. Clevers H. Modeling development and disease with organoids. Cell 2016;165:1586-1597 https://doi.org/10.1016/j.cell.2016.05.082
  15. Fujii M, Sato T. Somatic cell-derived organoids as prototypes of human epithelial tissues and diseases. Nat Mater 2021;20:156-169
  16. Sato T, Vries RG, Snippert HJ, et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 2009;459:262-265 https://doi.org/10.1038/nature07935
  17. Wang Y, Lin H, Zhao L, et al. Standard: human intestinal organoids. Cell Regen 2023;12:23
  18. Sun H, Zhang YX, Li YM. Generation of skin organoids: potential opportunities and challenges. Front Cell Dev Biol 2021;9:709824
  19. Ganesh K, Wu C, O'Rourke KP, et al. A rectal cancer organoid platform to study individual responses to chemoradiation. Nat Med 2019;25:1607-1614 https://doi.org/10.1038/s41591-019-0584-2
  20. de Jongh D, Massey EK; VANGUARD consortium; Bunnik EM. Organoids: a systematic review of ethical issues. Stem Cell Res Ther 2022;13:337
  21. Geraghty RJ, Capes-Davis A, Davis JM, et al. Guidelines for the use of cell lines in biomedical research. Br J Cancer 2014;111:1021-1046
  22. Sullivan S, Stacey GN, Akazawa C, et al. Quality control guidelines for clinical-grade human induced pluripotent stem cell lines. Regen Med 2018;13:859-866 https://doi.org/10.2217/rme-2018-0095
  23. Steeg R, Mueller SC, Mah N, et al. EBiSC best practice: how to ensure optimal generation, qualification, and distribution of iPSC lines. Stem Cell Reports 2021;16:1853-1867 https://doi.org/10.1016/j.stemcr.2021.07.009
  24. Rohani L, Johnson AA, Naghsh P, Rancourt DE, Ulrich H, Holland H. Concise review: molecular cytogenetics and quality control: clinical guardians for pluripotent stem cells. Stem Cells Transl Med 2018;7:867-875 https://doi.org/10.1002/sctm.18-0087
  25. Yin X, Mead BE, Safaee H, Langer R, Karp JM, Levy O. Engineering stem cell organoids. Cell Stem Cell 2016;18:25-38 https://doi.org/10.1016/j.stem.2015.12.005
  26. Shang Z, Feng H, Xia L. The suppression effects of fat mass and obesity associated gene on the hair follicle-derived neural crest stem cells differentiating into melanocyte by N6-methyladenosine modifying microphthalmia-associated transcription factor. Int J Stem Cells 2023;16:135-144 https://doi.org/10.15283/ijsc22106
  27. Zhao Z, Chen X, Dowbaj AM, et al. Organoids. Nat Rev Methods Primers 2022;2:94
  28. Kim Y, Ju JH. Generation of 3D skin organoid from cord blood-derived induced pluripotent stem cells. J Vis Exp 2019;(146):e59297
  29. Posch W, Lass-Florl C, Wilflingseder D. Generation of human monocyte-derived dendritic cells from whole blood. J Vis Exp 2016;(118):54968
  30. Sachamitr P, Leishman AJ, Davies TJ, Fairchild PJ. Directed differentiation of human induced pluripotent stem cells into dendritic cells displaying tolerogenic properties and resembling the CD141＋ subset. Front Immunol 2018;8:1935
  31. Yousef H, Alhajj M, Sharma S. Anatomy, skin (integument), epidermis. StatPearls. StatPearls Publishing; 2024.
  32. Caloni F, De Angelis I, Hartung T. Replacement of animal testing by integrated approaches to testing and assessment (IATA): a call for in vivitrosi. Arch Toxicol 2022;96:1935-1950 https://doi.org/10.1007/s00204-022-03299-x
  33. Gadarowska D, Kalka J, Daniel-Wojcik A, Mrzyk I. Alternative methods for skin-sensitization assessment. Toxics 2022;10:740
  34. Everett JS, Sommers MS. Skin viscoelasticity: physiologic mechanisms, measurement issues, and application to nursing science. Biol Res Nurs 2013;15:338-346 https://doi.org/10.1177/1099800411434151
  35. Furbo S, Urbano PCM, Raskov HH, Troelsen JT, Kanstrup Fiehn AM, Gogenur I. Use of patient-derived organoids as a treatment selection model for colorectal cancer: a narrative review. Cancers (Basel) 2022;14:1069
  36. Han J, Kim S, Lee SH, et al. Me-too validation study for in vitro skin irritation test with a reconstructed human epidermis model, KeraSkinTM for OECD test guideline 439. Regul Toxicol Pharmacol 2020;117:104725
  37. OECD. Test No. 429: skin sensitisation: local lymph node assay. OECD; 2010.
  38. OECD. Test No. 442A: skin sensitization: local lymph node assay: DA. OECD; 2010.
  39. OECD. Test No. 442B: skin sensitization: local lymph node assay: BrdU-ELISA or -FCM. OECD; 2018.